What's so surprising? Any unwritten rule to confine postings at other counters? What's there to hide? Didn't I mention earlier we picked up Pharma and Dpharma at 1.55 back in March 2020 at start of pandemic?
Tuan Faris, you're most welcome. We love to share for we care, as in forum of all other counters.. As investors, we like to gather logical and rational information for mutual benefits. Two way traffic... Salam!
Obliged Mr Yeoh, we should always present FACTS and FIGURES for fellow investors and not shout ridiculous TP for nothing. Reflects badly on oneself. Good luck!
Ini jerung busuk punya orang.Dia mau makan satu orang sahaja.Kasi jual harga kasi turun.Belakang dia masuk balik.Kannaya.Harga naik sikit dia jual.Billis atas pucuk tunggu sampai tua.Last tak bole tahan cut loss.Puiih punya jerung.
Kanger working with Duopharma to distribute Sinopharm to Malaysia, with the previously built connection in Sabah and Sarawak, now both of them will work together for the distributionship.
WHO Emergency Committee HAVE JUST warned of more dangerous variants strains as more Rich Nations are ordering millions of Extra Booster Shots /vaccine - This is the cause of Vaccine Rush and short supply . DUOPHARMA ,a registration holder -too Precious
Think about few million foreign workers in Malaysia required vaccination. The government won't pay for foreign worker's vaccination, private companies have to pay for it. The private market is huge. (Some banglas managed to get vaccination appointment in mysejathera, I think government going to stop this)
Mr Yeoh,...don't understand how other ASEAN colleague countries would wish to procure any Vaccine from a third party, and NOT directly from the Vendor at source? Furthermore, China is not too far away as Russia whom have signed Term Papers with Dpharma to distribute Sputnik V in Malaysia, transfer their technology to Dpharma, and also wish to appoint Dpharma as their Asian Manufacturing Hub. Now, that's glorious, isn't it?
And as announced by the health director-general, the Drug Control Authority has approved Sinopharm, which will be brought in by Duopharma.
“For now, it’s only for the private market. But in case we don’t have enough supply for the national immunisation programme (PICK), we can also procure Sinopharm vaccines from Duopharma,” he said.
Is it necessary to waste time and money to test Booster to expel fears of low efficacy (65%) of Sinovac??? To what results and purpose???
JUST GIVE A RELIABLE AND TRUSTED VACCINE, ONCE AND FOR ALL..case closed.
"More recently, a Hong Kong study indicated that those who received the Pfizer-BioNTech vaccine had 10 times the amount of antibodies than those given the Sinovac vaccine."
"Chile and Seychelles, which used China-made vaccines, had reported an increase in the number of Covid-19 cases despite having a very high vaccination rate of between 65% and 70% of their populations."
“Analysis has shown that Sinovac only has a 65% efficacy against symptomatic infection in contrast to a 96% and 92% efficacy of the Pfizer and AstraZeneca vaccines respectively.”
THIS SAYS IT ALL....: just take a DIFFERENT VACCINE, ONCE AND FOR ALL
"He said this was why countries that have used the Sinovac vaccine are reviewing their strategy, including proposing the mixing of vaccines and booster doses to overcome any shortcomings of the Sinovac vaccine."
And before anyone gets any bright ideas, the 3rd or Booster shot is ACTUALLY a mix Vaccine.....meaning to use ANOTHER RELIABLE vaccine to overcome any shortcomings from Sinovac.
SAY AGAIN,....3rd BOOSTER SHOT, if necessary...1000% DEFINITELY, certainly NOT Sinovac. End of case, no further discussions.
What else do you expect MOSTI to do? Faced with rising cases exceeding 13,000 and deaths of 80-120 each day? Even on increased vaccinations of 300-400K now, cases are as rampant as wild bush fires.
What seems to be the light at the end of a tunnel with more inoculations, turns out to be wet firecrackers, headlights from an on rushing truck.
There's no other choice but to switch vaccine, for the greater good of Rakyat. Although, he has graciously offer consolation on a Plan B and to deny low efficacy.
Consider it most unfortunate for Pharma to have keys to the front door, but not the keys to the Vault. Maybe better luck next time.
Money is secondary, when compared with lost lives...One last question, straight to the point...HAVE YOU EVER LOST A CLOSE FRIEND, RELATIVE, LOVED ONES TO COVID?
Report 2: Kanger International executive director Steven Kuah told reporters that, “the process of registering the Sinopharm vaccine (with NPRA) has started and we hope to receive some good news on its approval soon.”
Report 6: The states are free to negotiate with drug makers Moderna and Sinopharm, whose vaccines have been approved by the World Health Organization . Khairy said that as long as the vaccines have been given the green light by the National Pharmaceutical Regulatory Agency, the states are free to procure them.
Khairy also mentioned that Covid-19 vaccines will enter the private market by August. He said that private vaccination will help the government ramp up the national Covid-19 vaccination programme, as those who are able to pay for the vaccines will be able to do so.
“I also anticipate by about August, we will have a private vaccine market. So right now, it’s difficult for private because vaccines are in short supply. But by August, I think that there will be SOME COMPANIES who WILL BE APPROVED to bring in SOME PRIVATE VACCINES from China. I know Sinopharm and all that are going to be registered here,” Khairy added.
“That’s also part of the plan. I’ve been talking to the Ministry of Health to ensure that the private market by August can take off to help us.”
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
Report Abuse
Please Sign In to report this post as abuse.
Market Buzz
No result.
Featured Posts
MQ Trader
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: Carlo Rino Group Berhad, a leading fashion retailer of women’s handbags, footwear, and accessories, aims to list on the ACE Market!
MQ Trader 124 views | 22 h ago
0:17
New IPO: A homegrown air fragrance company, Vanzo Holdings Berhad aims to list on the Ace Market!
MQ Trader 233 views | 1 d ago
0:17
New IPO: Winstar Capital Berhad, a specialist in the extrusion of aluminium profiles and fabrication of aluminium ladders aims to list on the ACE Market!
MQ Trader 403 views | 2 d ago
0:17
New IPO: Topvision Eye Specialist Berhad, specializing in medical eye care services aims to list on the ACE Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Trevor777
3,055 posts
Posted by Trevor777 > 2021-07-16 11:41 | Report Abuse
Sinopharm to Dpharma.....good news.